Information on the Target
Hedonai is a prominent brand in the laser hair removal and aesthetic medicine sector in Spain. The company specializes in non-invasive medical-aesthetic treatments, including laser hair removal and electro-fitness procedures. Established as a leader in its field, Hedonai operates over 40 centers across major Spanish cities, strategically placing more than 50% of its locations within El Corte Inglés department stores.
Since its acquisition by Fondo Nazca II in October 2004, Hedonai has experienced substantial growth, expanding from just three centers to over 40. The company has undergone professionalization under new management, repositioned its brand towards a high-quality market segment, and solidified its status as the primary laser hair removal provider within El Corte Inglés's Beauty and Health line. This strategic repositioning has allowed Hedonai to focus on rapidly growing segments, particularly in laser hair removal and electro-fitness.
Industry Overview in Spain
The aesthetic medicine and beauty industry in Spain has witnessed significant expansion, driven by evolving consumer preferences and increasing awareness of non-invasive treatment options. The rising demand for aesthetic procedures, particularly laser hair removal, has positioned companies like Hedonai at the forefront of this growing market. Consumers are now more inclined to invest in self-care, prioritizing beauty and wellness, which has encouraged the emergence of specialized providers.
In recent years, the sector has also benefited from advancements in technology, enabling safer and more effective treatments. As competition increases among aesthetic clinics, establishing strategic partnerships and location-based expansions have become crucial for maintaining market share. The positioning of facilities within well-known retail chains, such as El Corte Inglés, has demonstrated effective customer outreach and convenience.
Furthermore, the trend towards health and wellness has enhanced the appeal of aesthetic treatments among a broader demographic, not just millennials but also older adult populations seeking these services. This demographic shift continues to shape industry dynamics, as businesses adapt their offerings to meet new customer segments.
Spain’s economic stabilization and growth have bolstered disposable income, allowing more individuals to access beauty services. As a result, the aesthetic industry is expected to maintain its upward trajectory, presenting continued investment opportunities for both domestic and international players.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The agreement between Fondo Nazca II and Vousse Corp, S.A. for the sale of Hedonai for €7.2 million reflects a strategic move to capitalize on the significant growth potential in the aesthetic medicine market. By merging Hedonai's well-established presence with Vousse’s existing operations, there is an opportunity to create a formidable entity in the Iberian market.
Moreover, Vousse’s plans to expand into the Latin American market present additional avenues for growth and diversification. This acquisition will allow Vousse to leverage Hedonai’s brand reputation, customer base, and proprietary knowledge in aesthetic procedures to drive expansive growth both domestically and internationally.
Information About the Investor
Vousse Corp, S.A. is a publicly traded company on the MAB, and it specializes in health and wellness services. With a portfolio of 54 centers and a strong customer base of 280,000 clients, Vousse is well-positioned to enhance its market presence through strategic acquisitions. The company's focus on growth in key markets underscores its ambition to become a leading player in the health and aesthetic sector.
With a vision to expand internationally, particularly in Latin America, Vousse aims to replicate its successful business model in new regions, driving significant value creation. This acquisition of Hedonai aligns with their strategic objectives, allowing for potential synergies and enhanced market presence in the competitive aesthetic landscape.
View of Dealert
The acquisition of Hedonai by Vousse Corp has the potential to be a strong investment, benefiting both parties involved. For Nazca, the sale allows them to realize significant returns on their investment while maintaining a stake in the new combined entity, enabling them to participate in future growth.
From Vousse’s perspective, integrating Hedonai enhances their market position and increases their service offerings. Leveraging Hedonai’s established brand reputation will likely attract new clients while retaining existing ones, facilitating customer loyalty amidst competition.
Moreover, the strategic placement of Hedonai’s centers within El Corte Inglés not only boosts visibility but also provides an advantageous retail environment. This positioning is paramount for attracting foot traffic and providing convenience for clients seeking aesthetic services.
In summary, the acquisition presents a robust opportunity for Vousse to expand its footprint in Spain and beyond. The anticipated growth in the aesthetic medicine sector, combined with the strategic advantages offered through this deal, suggests that this partnership could represent a significant value enhancement, making it an opportune investment for Vousse Corp.
Similar Deals
Aminolabs Nutrition → Zoka Pharma
2023
Abac Capital and Pronokal's management team → Pronokal
2023
Alantra PEF IV → 13 dental laboratories
2023
Asabys, Buenavista, GoHub Ventures, UI Investissement, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind, individual investors → Quibim
2025
Miura Partners → Centro Psicosanitario Galiani and Orientak
2025
Management team of Sterimed, IK Partners, Sagard, Les Amis de Sterimed → Sterimed
2025
Capitala Group → Novellum Longevity
2025
Vousse Corp., S.A.
invested in
Hedonai
in 2014
in a Management Buyout (MBO) deal
Disclosed details
Transaction Size: $7M